Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain
NCT07197645
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Bone Pain
Metastatic Bone Tumor
Bone Metastases in Subjects With Advanced Cancer
Interventions
DRUG:
153Sm-DOTMP
Sponsor
Telix Pharmaceuticals (Innovations) Pty Limited